MONOCLONAL ANTI-MECP2

Code: M6818-100UL D2-231

Application

Monoclonal Anti-MeCP2 antibody produced in mouse has been used in:immunoblottingimmunoprecipitationimmunostainingenzyme linked immunosorbent assay (ELISA)immunocy...


read more

Your Price
€498.00 100UL
€612.54 inc. VAT

Application

Monoclonal Anti-MeCP2 antibody produced in mouse has been used in:immunoblottingimmunoprecipitationimmunostainingenzyme linked immunosorbent assay (ELISA)immunocytochemistrywestern blot (0.1-0.2 μg/mL using nuclear cell extract of cultured Jurkat, human acute T cell leukemia cells, or cultured MCF7 human breast carcinoma)

Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.Immunoprecipitation (1 paper)Western Blotting (1 paper)

Biochem/physiol Actions

Methyl-CpG binding protein 2 (MeCP2) deacetylase (HDAC) repressive machinery via recruitment of the Sin 3A corepressor, thus removing acetyl groups from histones and consequently, silencing genes. Antibodies reacting specifically with MeCP2 may be used for studying chromatin remodeling effects on gene expression.

Methyl-CpG binding protein 2 (MeCP2) is a transcription modulator that binds methylated DNA. This protein regulates neuronal functions and central nervous system development. Alterations in MeCP2 have been associated with neurological diseases such as MECP2 duplication syndrome and Rett syndrome

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

Monoclonal Anti-MeCP2 (mouse IgG1 isotype) is derived from the Mec-168 hybridoma produced by the fusion of mouse myeloma cells (NS1) and splenocytes from BALB/c mice immunized with a synthetic peptide corresponding to the C- terminus of human MeCP2. Methyl-CpG binding protein 2 (MeCP2) is the first methyl-CpG-binding protein to be isolated. This protein contains a methyl-CpG-binding domain (MBD) and a transcriptional repression domain (TRD).

Immunogen

synthetic peptide corresponding to the C-terminus (amino acids 471-486) of human MeCP2.

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.

antibody formpurified from hybridoma cell culture
antibody product typeprimary antibodies
biological sourcemouse
cloneMec-168, monoclonal
conjugateunconjugated
formbuffered aqueous solution
Gene Informationhuman ... MECP2(4204)mouse ... Mecp2(17257)rat ... Mecp2(29386)
isotypeIgG1
mol wtantigen ~75 kDa
packagingantibody small pack of 25 µL
Quality Level200
shipped indry ice
species reactivityrat, mouse, human
storage temp.−20°C
technique(s)indirect ELISA: suitable, immunocytochemistry: suitable, western blot: 0.1-0.2 µg/mL using nuclear cell extract of cultured Jurkat, human acute T cell leukemia cells, or cultured MCF7 human breast carcinoma., microarray: suitable
UniProt accession no.P51608
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN


GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.